PANCREAZE DR 4,200 UNIT CAP
PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE$1.1440per EA
Strength
24600; 4200; 14200 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Vivus LLCNDC
62541040210
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2020
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022523On Market Since
4/12/2010
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.